Nisa Investment Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-345
| Closed | -$6.4K | – | 2807 |
|
|
2023
Q3 | $6.4K | Hold |
345
| – | – | ﹤0.01% | 2258 |
|
|
2023
Q2 | $3.82K | Sell |
345
-22
| -6% | -$307 | ﹤0.01% | 2337 |
|
|
2023
Q1 | $5K | Hold |
367
| – | – | ﹤0.01% | 2250 |
|
|
2022
Q4 | $5K | Buy |
367
+22
| +6% | +$312 | ﹤0.01% | 2302 |
|
|
2022
Q3 | $5K | Hold |
345
| – | – | ﹤0.01% | 2307 |
|
|
2022
Q2 | $5K | Hold |
345
| – | – | ﹤0.01% | 2278 |
|
|
2022
Q1 | $6K | Hold |
345
| – | – | ﹤0.01% | 2301 |
|
|
2021
Q4 | $6K | Sell |
345
-3,700
| -91% | -$62.4K | ﹤0.01% | 2086 |
|
|
2021
Q3 | $60 | Hold |
4,045
| – | – | ﹤0.01% | 1896 |
|
|
2021
Q2 | $81 | Buy |
4,045
+3,700
| +1,072% | +$73.4K | ﹤0.01% | 1797 |
|
|
2021
Q1 | $8 | Hold |
345
| – | – | ﹤0.01% | 2235 |
|
|
2020
Q4 | $9K | Sell |
345
-850
| -71% | -$28.2K | ﹤0.01% | 2226 |
|
|
2020
Q3 | $50K | Buy |
1,195
+1,000
| +513% | +$45.9K | ﹤0.01% | 1813 |
|
|
2020
Q2 | $9K | Buy |
195
+15
| +8% | +$1.16K | ﹤0.01% | 1951 |
|
|
2020
Q1 | $11K | Sell |
180
-120
| -40% | -$10.8K | ﹤0.01% | 1843 |
|
|
2019
Q4 | $37K | Buy |
300
+200
| +200% | +$17.9K | ﹤0.01% | 1584 |
|
|
2019
Q3 | $7K | Hold |
100
| – | – | ﹤0.01% | 1857 |
|
|
2019
Q2 | $8K | Hold |
100
| – | – | ﹤0.01% | 1821 |
|
|
2019
Q1 | $11K | Hold |
100
| – | – | ﹤0.01% | 1732 |
|
|
2018
Q4 | $10K | Hold |
100
| – | – | ﹤0.01% | 1663 |
|
|
2018
Q3 | $13K | Buy |
+100
| New | +$10.6K | ﹤0.01% | 1657 |
|
Nisa Investment Advisors's ICPT Position: Q4 2023 in Review
Nisa Investment Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 345 shares — an estimated $6.4K sold.
Nisa Investment Advisors first reported a position in ICPT in Q3 2018 and held it in 21 quarters. The position peaked at $50K in Q3 2020. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Nisa Investment Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Nisa Investment Advisors sold 345 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $6.4K.
- Nisa Investment Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2018 and held it in 21 quarters.
- Nisa Investment Advisors's Intercept Pharmaceuticals, Inc. position peaked at $50K in Q3 2020.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Nisa Investment Advisors's 13F filing for Q4 2023, filed 25 Jan 2024.